Skip to Content
Merck
CN

196835

2,4,6-Trifluoroaniline

≥97%

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View

About This Item

Linear Formula:
F3C6H2NH2
CAS Number:
Molecular Weight:
147.10
NACRES:
NA.22
PubChem Substance ID:
UNSPSC Code:
12352100
EC Number:
206-660-8
MDL number:
Assay:
≥97%
Form:
solid
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist


Quality Level

assay

≥97%

form

solid

bp

57 °C/22 mmHg (lit.)

mp

33-37 °C (lit.)

functional group

fluoro

SMILES string

Nc1c(F)cc(F)cc1F

InChI

1S/C6H4F3N/c7-3-1-4(8)6(10)5(9)2-3/h1-2H,10H2

InChI key

BJSVKBGQDHUBHZ-UHFFFAOYSA-N

Application

2,4,6-Trifluoroaniline was used in the synthesis of:
  • 3-nitro-2,4,6 -trifluoroacetanilide
  • series of N′-phenyl-N-(1- phenyl cyclopentyl)-methyl ureas
  • 4-substituted 2,6-difluoro N-aryl pyridinones


signalword

Danger

Hazard Classifications

Acute Tox. 4 Oral - Eye Dam. 1 - Flam. Sol. 2 - Skin Irrit. 2 - STOT SE 3

target_organs

Respiratory system

Storage Class

4.1B - Flammable solid hazardous materials

wgk

WGK 3

ppe

dust mask type N95 (US), Eyeshields, Gloves

Regulatory Information

新产品

This item has



Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library



EPR spectroscopy of a diaza derivative of meta-xylylene.
Haider K, et al.
Tetrahedron Letters, 30(10), 1225-1228 (1989)
Shaun R Selness et al.
Bioorganic & medicinal chemistry letters, 21(13), 4059-4065 (2011-06-07)
A series of N-aryl pyridinone inhibitors of p38 mitogen activated protein (MAP) kinase were designed and prepared based on the screening hit SC-25028 (1) and structural comparisons to VX-745 (5). The focus of the investigation targeted the dependence of potency
T S Purchase et al.
Bioorganic & medicinal chemistry, 5(4), 739-747 (1997-04-01)
Our continued interest in developing novel, potent acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors, and our discovery of several active series of disubstituted urea ACAT inhibitors, have led us to investigate a series of trisubstituted ureas that are structural hybrids of our disubstituted



Global Trade Item Number

SKUGTIN
196835-5G04061838762245